Bluebird bio Inc’s filing revealed that its Chief Medical Officer Colvin Richard A unloaded Company’s shares for reported $176.0 on Jan 06 ’25. In the deal valued at $9.24 per share,19 shares were sold. As a result of this transaction, Colvin Richard A now holds 8,257 shares worth roughly $68945.95.
Then, Obenshain Andrew sold 140 shares, generating $1,294 in total proceeds. Upon selling the shares at $9.24, the President and CEO now owns 18,571 shares.
Before that, Colvin Richard A bought 19 shares. Bluebird bio Inc shares valued at $166 were divested by the Officer at a price of $8.74 per share.
JP Morgan downgraded its Bluebird bio Inc [BLUE] rating to an Underweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in mid November from “a Buy” to “a Neutral”. JP Morgan also remained covering BLUE and has decreased its forecast on August 15, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. HSBC Securities revised its rating on December 11, 2023. It rated BLUE as “a Reduce” which previously was an “a Hold”.
Price Performance Review of BLUE
On Friday, Bluebird bio Inc [NASDAQ:BLUE] saw its stock jump 1.09% to $8.35. Over the last five days, the stock has lost -1.30%. Bluebird bio Inc shares have risen nearly 0.12% since the year began. Nevertheless, the stocks have fallen -70.39% over the past one year. While a 52-week high of $38.40 was reached on 01/06/25, a 52-week low of $5.80 was recorded on 01/16/25. SMA at 50 days reached $8.15, while 200 days put it at $14.66.
Levels Of Support And Resistance For BLUE Stock
The 24-hour chart illustrates a support level at 8.15, which if violated will result in even more drops to 7.96. On the upside, there is a resistance level at 8.50. A further resistance level may holdings at 8.66. The Relative Strength Index (RSI) on the 14-day chart is 49.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.25%. Stochastics %K at 24.52% indicates the stock is a holding.
How much short interest is there in Bluebird bio Inc?
A steep rise in short interest was recorded in Bluebird bio Inc stocks on 2024-10-31, dropping by -1.29 million shares to a total of 47.71 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 48.99 million shares. There was a decline of -2.69%, which implies that there is a negative sentiment for the stock.
